Antiprolactinoma Effect of Hordenine by Inhibiting MAPK Signaling Pathway Activation in Rats

Prolactinomas are harmful to human health, and the clinical first-line treatment drug is bromocriptine. However, 20% prolactinomas patients did not respond to bromocriptine. Hordenine is an alkaloid separated from Fructus Hordei Germinatus, which showed significant antihyperprolactinemia activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiong, Guo, Run-zhu, Ma, Li, Ding, Qiao-yan, Meng, Jun-hua, Chen, Yong-gang, Wu, Jin-hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195642/
https://www.ncbi.nlm.nih.gov/pubmed/32382283
http://dx.doi.org/10.1155/2020/3107290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195642/
https://www.ncbi.nlm.nih.gov/pubmed/32382283
http://dx.doi.org/10.1155/2020/3107290

Ejemplares similares